In Recombinant Antibodies for Cancer Therapy: Methods and Protocols, Martin
Welschoff and Jurgen Krauss present a collection of carefully selected protocols
for the design, construction, and characterization of novel anticancer
therapeutics based on recombinant antibody technology. These readily
reproducible methods include coverage of hybridoma-derived recombinant
antibodies, recombinant antibody fragments from phagemid-displayed antibody
repertoires, antibody fragments with additional properties, and large-scale
production of recombinant antibodies for clinical applications. Concise review
articles also survey the current status of recombinant antibodies in cancer
therapy, as well as the generation of antibody molecules through antibody
engineering.